Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys
- PMID: 9537682
- DOI: 10.1007/s002130050538
Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys
Abstract
Increased distractibility is associated with both Alzheimer's disease and attention deficit disorder. The present study examined the effects of (-)-nicotine and the novel central nicotinic receptor (nAChR) agonists ABT-418 [(S)-3-methyl-2-pyrrolidinyl)isoxazole] and ABT-089 [2-methyl-3-(2-(S)-pyrrolindinylmethoxy)pyridine dihydrochloride] on the delayed recall accuracy of adult monkeys exposed to distracting stimuli. Unpredictable exposure to a random visual array produced marked decrements in recall accuracy on trials with the shortest delay intervals, reducing the accuracy on these trials by 23.4%. Intramuscular (i.m.) administration of (-)-nicotine, in doses of 5.4-43.3 nmol/kg, attenuated the effect of the distractor, but did not completely prevent it. Both ABT-418 (2.0-16.2 nmol/kg, i.m.) and ABT-089 (16.4-32.8 nmol/kg, i.m.) prevented distractibility, producing increases of 7.5-25.0% in accuracy on trials disrupted by distractor exposure. Further, both compounds also improved accuracy on trials during which distractors were not presented, an effect which was not observed after (-)-nicotine administration. Nicotinic-mediated side effects were not observed following administration of any compound. Thus, nAChR stimulation reduces distractibility in adult monkeys and may, therefore, represent a target for the pharmacologic treatment of disorders associated with susceptibility to distraction. ABT-418 and ABT-089 appear to be particularly useful in this regard, a likely result of their selective agonist activity at nAChRs expressed in the brain.
Similar articles
-
Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys.J Pharmacol Exp Ther. 2002 Apr;301(1):284-92. doi: 10.1124/jpet.301.1.284. J Pharmacol Exp Ther. 2002. PMID: 11907185
-
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.J Pharmacol Exp Ther. 1994 Jul;270(1):310-8. J Pharmacol Exp Ther. 1994. PMID: 7518514
-
Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement.Psychopharmacology (Berl). 1995 Aug;120(3):256-66. doi: 10.1007/BF02311172. Psychopharmacology (Berl). 1995. PMID: 8524972
-
Cholinergic channel activators: novel opportunities for the treatment of CNS disorders.Proc West Pharmacol Soc. 1995;38:127-30. Proc West Pharmacol Soc. 1995. PMID: 7480004 Review.
-
Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.Biochem Pharmacol. 2007 Oct 15;74(8):1212-23. doi: 10.1016/j.bcp.2007.07.002. Epub 2007 Jul 7. Biochem Pharmacol. 2007. PMID: 17689498 Free PMC article. Review.
Cited by
-
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders.Biochem Pharmacol. 2015 Oct 15;97(4):388-398. doi: 10.1016/j.bcp.2015.07.027. Epub 2015 Jul 29. Biochem Pharmacol. 2015. PMID: 26231940 Free PMC article. Review.
-
The enhancement of contextual fear conditioning by ABT-418.Behav Pharmacol. 2010 May;21(3):246-9. doi: 10.1097/FBP.0b013e32833a5b9d. Behav Pharmacol. 2010. PMID: 20400893 Free PMC article.
-
The subcortical and neurochemical organization of the ventral and dorsal attention networks.Commun Biol. 2022 Dec 7;5(1):1343. doi: 10.1038/s42003-022-04281-0. Commun Biol. 2022. PMID: 36477440 Free PMC article.
-
Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential.Psychopharmacology (Berl). 2003 Sep;169(2):150-60. doi: 10.1007/s00213-003-1483-1. Epub 2003 May 27. Psychopharmacology (Berl). 2003. PMID: 12768267
-
α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation.Br J Pharmacol. 2015 Oct;172(20):4919-31. doi: 10.1111/bph.13260. Epub 2015 Sep 22. Br J Pharmacol. 2015. PMID: 26222090 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources